You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
9 June 2026 - Adcentrx Therapeutics, a California-based clinical-stage biotechnology company advancing Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, announced on Monday that the China National Medic...
9 June 2026 - Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), an Israeli pharmaceutical company, announced on Monday that it has entered into a definitive agreement to acquire Colospan Ltd., an Israeli commercial-stage medical device company that is clai...
9 June 2026 - Argo Biopharmaceutical Co., Ltd., a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Monday that it has been selected to present Phase II updated results for BW-20805 at the European Associati...
8 June 2026 - Hangzhou Sciwind Biosciences Co Ltd, a China-based, commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, announced on Sunday that key data from a head-to-head stud...
8 June 2026 - Commercial-stage biotech company Antengene Corporation Limited (SEHK:6996) announced on Sunday that it has presented the first preclinical data on ATG-207, alpha masked and TGF beta RIII-biased CD3-TGF-beta bifunctional fusion protein i...
8 June 2026 - Chinese biotechnology company OriCell Therapeutics Holdings Limited announced on Sunday that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's National Medical Products Administra...